Assetmark Inc. Has $10.72 Million Holdings in Cardinal Health, Inc. $CAH

Assetmark Inc. decreased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 14.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 68,316 shares of the company’s stock after selling 11,101 shares during the quarter. Assetmark Inc.’s holdings in Cardinal Health were worth $10,723,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. SJS Investment Consulting Inc. boosted its position in shares of Cardinal Health by 1,363.6% during the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock valued at $25,000 after buying an additional 150 shares during the last quarter. Jones Financial Companies Lllp boosted its holdings in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares during the last quarter. Atlantic Edge Private Wealth Management LLC grew its stake in shares of Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after acquiring an additional 75 shares in the last quarter. American Capital Advisory LLC raised its holdings in shares of Cardinal Health by 5,200.0% in the third quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock valued at $33,000 after purchasing an additional 208 shares during the last quarter. Finally, Vermillion & White Wealth Management Group LLC lifted its position in shares of Cardinal Health by 55.0% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after purchasing an additional 71 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

More Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Recent quarterly results and underlying strength — Cardinal reported a Q4 EPS beat and revenue above expectations, with revenue up ~19% year-over-year, which analysts cite as supporting the stock’s upside. Cardinal Health’s (NYSE:CAH) Solid Earnings Are Supported By Other Strong Factors
• Positive Sentiment: Dividend confirmed — the Board approved a quarterly dividend of $0.5107 per share (payable Apr 15; record Apr 1). The cash return reinforces income appeal and signals confidence in cash flow. Cardinal Health Board of Directors Approves Quarterly Dividend
• Positive Sentiment: Analyst lift — JPMorgan raised its price target to $243, providing a tangible upside anchor for investors and helping sentiment. JPMorgan Chase Increases Cardinal Health Price Target
• Positive Sentiment: Zacks momentum & valuation coverage — CAH was added to Zacks’ Rank #1 momentum list and several Zacks pieces highlight undervaluation and a favorable long-term value case, which can attract momentum and value investors. Best Momentum Stock to Buy for February 13th Are Investors Undervaluing Cardinal Health?
• Neutral Sentiment: Kalkine notes logistics/reliability improvements on the NYSE composite — operational reliability updates are constructive but are incremental near-term drivers. Cardinal Health Boosts Logistics Reliability
• Neutral Sentiment: Analyst Q&A from the earnings call — the transcript highlights management’s priorities and risk items; useful for longer-term fundamental assessment but not an immediate catalyst. The 5 Most Interesting Analyst Questions From Cardinal Health’s Q4 Earnings Call

Cardinal Health Stock Performance

Shares of Cardinal Health stock opened at $220.72 on Monday. The stock has a market capitalization of $51.94 billion, a P/E ratio of 31.76, a P/E/G ratio of 1.42 and a beta of 0.64. Cardinal Health, Inc. has a 52-week low of $120.72 and a 52-week high of $230.81. The stock’s 50-day simple moving average is $208.84 and its 200 day simple moving average is $182.54.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, February 5th. The company reported $2.63 earnings per share for the quarter, topping the consensus estimate of $2.31 by $0.32. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The firm had revenue of $65.63 billion during the quarter, compared to the consensus estimate of $64.88 billion. During the same quarter last year, the company earned $1.93 earnings per share. The company’s revenue was up 18.8% on a year-over-year basis. Equities research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be given a dividend of $0.5107 per share. The ex-dividend date is Wednesday, April 1st. This represents a $2.04 annualized dividend and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio is currently 29.35%.

Analyst Ratings Changes

A number of brokerages have issued reports on CAH. Jefferies Financial Group upped their price objective on shares of Cardinal Health from $220.00 to $270.00 and gave the stock a “buy” rating in a research report on Thursday, January 22nd. JPMorgan Chase & Co. upped their target price on Cardinal Health from $209.00 to $243.00 and gave the company a “neutral” rating in a report on Tuesday, February 10th. Evercore ISI increased their price target on Cardinal Health from $250.00 to $260.00 in a research report on Friday, February 6th. Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Finally, Argus raised their target price on Cardinal Health from $232.00 to $248.00 and gave the company a “buy” rating in a research report on Wednesday, February 11th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average price target of $245.19.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.